More than 200 scientists and clinical investigators gathered to share insights and learn more about translational and clinical neuroscience research underway at the UK.
The Sanders-Brown Center on Aging Alzheimer's Disease Center has been awarded an $8.25 million, five-year grant from the National Institutes of Health (NIH) to continue and further research and clinical initiatives geared toward treating Alzheimer's disease.
UK has signed a membership agreement to join the TriNetX network, a leader in international clinical research networks, in order to optimize clinical trial design and advance clinical research for UK programs.
Kentucky Children’s Hospital is one of multiple sites around the nation participating in an experimental trial testing the safety and efficacy of a Biomarin pharmaceutical that reduces concentrations of phenylalanine in the bloodstream.
UK sent a delegation of executive, clinical and research leaders to join national thought-leaders and policymakers at the 2016 National Rx Drug Abuse and Heroin Summit.
High school freshmen in Kentucky are integrating physics, health, communication and technology through a collaborative, web-based project with scientists and students at the University of Kentucky.